Improved glucose regulation in type 2 diabetic patients with DPP-4 inhibitors: focus on alpha and beta cell function and lipid metabolism
Crossref DOI link: https://doi.org/10.1007/s00125-016-3899-2
Published Online: 2016-02-19
Published Print: 2016-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ahrén, Bo
Foley, James E.
Funding for this research was provided by:
Novartis Pharma AG
Text and Data Mining valid from 2016-02-19